Post hoc data analysis concluded that sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, improved glycemic control after one year in patients with normal and mildly reduced kidney functionTHE WOODLANDS, ...

A new study links AKI recovery thresholds to long-term kidney failure and mortality risk. Discover why a 10% creatinine recovery matters.

Concern is growing about the rising number of Barbadians requiring dialysis for kidney disease, with advocates warning that the country’s health system ...

Cutting down on sodium when you have IgAN can help preserve your kidney function. Learn ways to drop salt without forgetting ...

An unprecedented effort to reverse the effects of a racially biased medical test that blocked or delayed Black people from ...

ODESSA, Texas (KMID/KPEJ) – “We have almost 37 million people suffering from kidney disease in America. One in three others ...

A 14 year-old pupil has been forced to wear incontinence pads to class after ketamine use damaged her bladder, a school ...

The current kidney care model—focused on late-stage disease and in-center hemodialysis—is unsustainable, because of costs, environmental burden, poor outcomes, and reduced quality of life.

A recent study links chronic kidney disease with other major conditions like diabetes, high blood pressure, and obesity.

A lot gets done here at the Meals on Wheels People kitchen in Southwest Portland. People get to work bright and early at 5:30 ...

Vertex Pharmaceuticals VRTX announced positive data from an interim analysis of the ongoing phase III RAINER study, which evaluated its investigational drug povetacicept for IgA nephropathy (IgAN) ...

Povetacicept significantly reduced proteinuria in patients with IgA nephropathy in the RAINIER trial, supporting an upcoming FDA submission.